You're one step closer to unlocking our suite of comprehensive and robust tools.
Fill out the form so we can connect you to the right person.
Eurofins to acquire Villapharma in Spain
Shareholder Advocates Say New SEC Policy To Prompt Litigation, Less Transparency
Groups Urge Business Roundtable CEOs To Act On New Corporate Purpose Declaration
State of South Korean OTT Video: Subscription
Global Streaming Media Device Sales Forecast To Flatten In 5 Year Outlook
Eurofins Scientific SE is acquiring Villapharma Research SL in Spain for undisclosed terms.
The transaction is expected to close in February 2017 and will help Eurofins reinforce its footprint in discovery pharmacology.
Villapharma is a provider of organic synthesis and medical chemistry services to pharmaceutical and biotech companies. The company is expected to generate more than €6 million in revenues this year.